3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Smoldering Multiple Myeloma
1
Prostatic Neoplasms
1
Overweight
1
Obesity
1
Neoplasm Metastasis
1
Multiple Myeloma
1
Monoclonal Gammopathy of Undetermined Significance
1
Endometrial Neoplasms
1
Breast Neoplasms
1
Interventions
pembrolizumab
104
Specimen Handling
55
Magnetic Resonance Spectroscopy
48
Biopsy
46
Nivolumab
41
Paclitaxel
35
Gemcitabine
30
Radiosurgery
29
Carboplatin
28
Ipilimumab
22
Cyclophosphamide
22
Cisplatin
22
trastuzumab deruxtecan
21
Irinotecan
21
Capecitabine
19
Leucovorin
18
Fulvestrant
18
Cetuximab
18
130-nm albumin-bound paclitaxel
18
Pemetrexed
17
Fluorouracil
17
Docetaxel
17
Bevacizumab
17
Drug Therapy
16
Taxes
15
Oxaliplatin
15
olaparib
14
abemaciclib
14
Radiotherapy
14
Trastuzumab
13
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neoplasm Metastasis
×
Diet, Plant-Based
×
1 year
×
Clear all
NCT07189702
2026-04-08
BEND-MBEC
University of Rochester
Phase NA
Not yet recruiting
60 enrolled